VIM and gastric cancer: Vimentin, a marker of epithelial–mesenchymal transition (EMT), showed a lower expression in the sh-LINC00473 group than in the other group, suggesting that LINC00473 may affect the metastasis of GC cells via the EMT pathway in vivo (Fig. 4H).